title: Personalizing the duration of androgen-deprivation therapy use in the management of intermediate-risk prostate cancer.
authors.affiliation: Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA adamico@lroc.harvard.edu.
authors.forename: Anthony V
authors.initials: AV
authors.lastname: D'Amico
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods*